PerZeption Awarded NEI Phase 1 SBIR Grant for Age-related Macular Degeneration Study

Phase 1Positive

AI Analysis

Summary

PerZeption Inc. was awarded a Phase 1 SBIR grant from the National Eye Institute for a study on photostress recovery assessment in age-related macular degeneration. This grant represents early-stage research funding for the small biotech company.

Clinical Trial Data

Phase

Phase 1

Outcome Details

Phase 1 SBIR grant awarded

Importance:4/10

Sentiment:

0.60

SBIR grantPhase 1Age-related Macular DegenerationNational Eye Instituteophthalmology

Related Companies

$NHPAP

Read the original article

Published by PR Newswire Clinical Trials on September 12, 2026 1:26 AM

Read Original